Papers And Originals Controlled Trial of Dipyridamole in Cerebral Vascular Disease Br Med J 1969; 1 doi: https://doi.org/10.1136/bmj.1.5644.614 (Published 08 March 1969) Cite this as: Br Med J 1969;1:614 Article Related content Metrics Responses Peer review Related articles No related articles found. See more Chemoprevention of colorectal cancer in individuals with previous colorectal neoplasia: systematic review and network meta-analysis BMJ December 05, 2016, 355 i6188; DOI: https://doi.org/10.1136/bmj.i6188 NHS to fund large trial of pre-exposure prophylaxis for HIV prevention BMJ December 05, 2016, 355 i6537; DOI: https://doi.org/10.1136/bmj.i6537 Bill to boost medical research funding and speed drug approval passes US house BMJ December 01, 2016, 355 i6498; DOI: https://doi.org/10.1136/bmj.i6498 Alpha blockers for treatment of ureteric stones: systematic review and meta-analysis BMJ December 01, 2016, 355 i6112; DOI: https://doi.org/10.1136/bmj.i6112 Sixty seconds on . . . solanezumab BMJ November 29, 2016, 355 i6389; DOI: https://doi.org/10.1136/bmj.i6389 Cited by... Four Decades of Stroke Prevention TrialsFulltext PDF How Much Esprit Is in ESPRIT?Fulltext PDF Dipyridamole for Preventing Recurrent Ischemic Stroke and Other Vascular Events: A Meta-Analysis of Individual Patient Data From Randomized Controlled TrialsFulltext PDF Abstract Cochrane Review: Dipyridamole for Preventing Major Vascular Events in Patients With Vascular DiseaseFulltext PDF Abstract Thromboembolism and antithrombotic therapy in cerebrovascular diseaseFulltext PDF Abstract
